Related Experiment Video
Updated: Jun 29, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The MIF receptor CD74 in diabetic podocyte injury
Maria Dolores Sanchez-Niño1, Ana Belen Sanz, Pekka Ihalmo
1Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Fundación Renal Iñigo Alvarez de Toledo, Madrid, Spain.
Abstract:
Although metabolic derangement plays a central role in diabetic nephropathy, a better understanding of secondary mediators of injury may lead to new therapeutic strategies. Expression of macrophage migration inhibitory factor (MIF) is increased in experimental diabetic nephropathy, and increased tubulointerstitial mRNA expression of its receptor, CD74, has been observed in human diabetic nephropathy. Whether CD74 transduces MIF signals in podocytes, however, is unknown. Here, we found glomerular and tubulointerstitial CD74 mRNA expression to be increased in Pima Indians with type 2 diabetes and diabetic nephropathy. Immunohistochemistry confirmed the increased glomerular and tubular expression of CD74 in clinical and experimental diabetic nephropathy and localized glomerular CD74 to podocytes. In cultured human podocytes, CD74 was expressed at the cell surface, was upregulated by high concentrations of glucose and TNF-alpha, and was activated by MIF, leading to phosphorylation of extracellular signal-regulated kinase 1/2 and p38. High glucose also induced CD74 expression in a human proximal tubule cell line (HK2). In addition, MIF induced the expression of the inflammatory mediators TRAIL and monocyte chemoattractant protein 1 in podocytes and HK2 cells in a p38-dependent manner. These data suggest that CD74 acts as a receptor for MIF in podocytes and may play a role in the pathogenesis of diabetic nephropathy.
Insights
Macrophage migration inhibitory factor (MIF) receptor CD74 is elevated in diabetic nephropathy. CD74 in podocytes may mediate MIF
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Metabolic derangement is central to diabetic nephropathy.
- Macrophage migration inhibitory factor (MIF) and its receptor CD74 are implicated in diabetic nephropathy.
- The role of CD74 in podocyte signaling in diabetic nephropathy is unclear.
Purpose of the Study:
- To investigate the role of CD74 as a MIF receptor in podocytes in diabetic nephropathy.
- To examine CD74 expression and activation in diabetic nephropathy.
Main Methods:
- Assessed CD74 mRNA and protein expression in human diabetic nephropathy samples and experimental models.
- Utilized immunohistochemistry to localize CD74 in glomeruli.
- Cultured human podocytes and proximal tubule cells (HK2) were treated with high glucose, TNF-alpha, and MIF.
- Analyzed downstream signaling pathways including ERK1/2 and p38 phosphorylation.
- Measured inflammatory mediator expression (TRAIL, MCP-1).
Main Results:
- CD74 mRNA and protein expression were increased in glomeruli and tubules in diabetic nephropathy.
- Glomerular CD74 was localized to podocytes.
- High glucose and TNF-alpha upregulated cell surface CD74 in podocytes.
- MIF activated CD74 in podocytes, leading to ERK1/2 and p38 phosphorylation.
- MIF induced inflammatory mediator expression (TRAIL, MCP-1) in podocytes and HK2 cells via p38-dependent pathways.
Conclusions:
- CD74 functions as a MIF receptor in podocytes.
- CD74 signaling in podocytes contributes to inflammation and injury in diabetic nephropathy.
- Targeting the MIF-CD74 pathway may offer therapeutic strategies for diabetic nephropathy.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Foot Ulcer
Type I Diabetes II: Pathophysiology
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
